Senior insider sale
CHIEF FINANCIAL OFFICER at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$594.5K
16.30K shares
What this filing means
CLINE CHRISTOPHER R. plans to sell 16.30K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $594.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/15/2026ACC: 0001193125-26-155495
Officer· CHIEF FINANCIAL OFFICER
Since Feb 2026
16.30K
Shares to sell
$594.5K
Approx. market value
7.24K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Performance Restricted Stock Unit Vesting
Compensation
4/13/2026
7.24KTotal acquired7.24K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/13/2026 | Performance Restricted Stock Unit Vesting Compensation | 7.24K | — |
| Total | 7.24K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
9.00
Market value
$369.63
4/14/2026
—Completed
Units to sell
65.00
Market value
$1.9K
4/13/2026
—Completed
Units to sell
1.75K
Market value
$56.2K
2/4/2026
—Completed
Units to sell
7.24K
Market value
$232.6K
2/3/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.24K
Market value
$303.5K
4/14/2026
Total
Units
16.30K
Value
$594.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/14/2026 | 9.00 | $369.63 | — | Completed |
4/13/2026 | 65.00 | $1.9K | — | Completed |
2/4/2026 | 1.75K | $56.2K | — | Completed |
2/3/2026 | 7.24K | $232.6K | — | Completed |
| Planned — Approximate Date | ||||
4/14/2026 | 7.24K | $303.5K | NASDAQ | Planned |
| Total | 16.30K | $594.5K | ||